Article in Circulation research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Peter J MohlerFrom the Dorothy M. Davis Heart and Lung Research Institute, College of Medicine (P.J.M., T.J.H.), Department of Physiology & Cell Biology (P.J.M.), Division of Cardiovascular Medicine, Department of Internal Medicine, (P.J.M., T.J.H.), The Ohio State University College of Medicine and Wexner Medical Center, Columbus; and Department of Biomedical Engineering, The Ohio State University College of Engineering & Cell Biology, Columbus (T.J.H.). peter.mohler@osumc.edu.
Thomas J HundFrom the Dorothy M. Davis Heart and Lung Research Institute, College of Medicine (P.J.M., T.J.H.), Department of Physiology & Cell Biology (P.J.M.), Division of Cardiovascular Medicine, Department of Internal Medicine, (P.J.M., T.J.H.), The Ohio State University College of Medicine and Wexner Medical Center, Columbus; and Department of Biomedical Engineering, The Ohio State University College of Engineering & Cell Biology, Columbus (T.J.H.).
Funding
Defining novel mechanisms for human arrhythmiaR35HL135754 · NHLBI · OHIO STATE UNIVERSITY · PI MOHLER, PETER J. · 2017 to 2023
$6.0M
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitabilityR01HL083422 · NHLBI · VANDERBILT UNIVERSITY · PI MOHLER, PETER J. · 2006 to 2016
$3.8M
Defining novel mechanisms for regulation of atrial INa and arrhythmiasR01HL134824 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY, MOHLER, PETER J. · 2017 to 2020
$3.0M
EHD proteins in cardiac membrane protein targeting and remodelingR01HL114383 · NHLBI · OHIO STATE UNIVERSITY · PI BOYDEN, PENELOPE ALTMAN, MOHLER, PETER J. · 2013 to 2016
$2.1M
CaMKII-dependent regulation of cardiac excitabilityR01HL114893 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY · 2012 to 2016
$1.9M
Spectrin-based regulation of cardiac remodeling and heart failureR01HL135096 · NHLBI · OHIO STATE UNIVERSITY · PI HUND, THOMAS JEFFREY · 2017 to 2020
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Novel Pathways for Regulation of Sinoatrial Node Plasticity and Heart Rate. · full record | OpenQuestion